# Annovis Bio, Inc.: Form 8-K, filed Dec 9, 2024

- Company: [Annovis Bio, Inc.](/companies/anvs.md) (CIK 1477845)
- Form: 8-K
- Filed: 2024-12-09
- Accepted by EDGAR: Dec 9, 2024, 16:15 ET
- Period: 2024-12-04
- Accession: 0001104659-24-126761
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1477845/000110465924126761/tm2430528d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1477845/000110465924126761/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1477845/000110465924126761/tm2430528d1_8k.htm

Filed Dec 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-126761. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
